TrialJAMA oncology2020

FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial.

Haeseong Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.